Insulin therapy

Insulin therapy is recommended for patients with type 2 diabetes mellitus and an initial A1C level greater than 9 percent, or if diabetes is uncontrolled despite optimal oral glycemic therapy. Insulin therapy may be initiated as augmentation, starting at 0.3 unit per kg, or as replacement, starting at 0.6 to 1.0 unit per kg. When using replacement therapy, 50 percent of the total daily insulin dose is given as basal, and 50 percent as bolus, divided up before breakfast, lunch, and dinner. Augmentation therapy can include basal or bolus insulin. Replacement therapy includes basal-bolus insulin and correction or premixed insulin.

    Related Conference of Insulin therapy

    September 28-29, 2018

    2nd International Conference on Diabetes and Diabetic Nursing Care

    Montreal, Quebec, Canada
    November 21-22, 2018

    14th World Congress on Endocrinology & Diabetes

    Paris, France
    November 26-27, 2018

    26th International Diabetes and Healthcare Conference

    Helsinki, Finland
    November 26-27, 2018

    13th European Diabetes and Endocrinology Congress

    Dublin, Ireland

    March 28-29, 2019

    21st Asia Pacific Diabetes Conference

    Osaka,Japan
    May 16-17, 2019

    2nd Global Meeting on Diabetes and Endocrinology

    Abu Dhabi, UAE

    28th European Diabetes Congress

    June 10-11, 2019 | Edinburgh, Scotland
    July 24-25, 2019

    29th World Diabetes & Heart Congress

    Melbourne, Australia
    Oct 03-04, 2019

    Euro Diabetes Congress & Expo

    | Paris, France

    Insulin therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in